PANKAJ KUMAR, M.D.

Nuclear medicine study from skull base to mid-thigh with ct scan

Ct scan of abdomen and pelvis with contrast

Ct scan of chest with contrast

Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries

Injection, pegfilgrastim, excludes biosimilar, 0.5 mg

New patient office or other outpatient visit, 60-74 minutes

Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l

Administration of chemotherapy into vein, 1 hour or less

Leuprolide acetate (for depot suspension), 7.5 mg

New patient office or other outpatient visit, 45-59 minutes

Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes

Established patient office or other outpatient visit, 40-54 minutes

Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle

New patient office or other outpatient visit, 30-44 minutes

Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less

Administration of additional new drug or substance into vein, 1 hour or less

Established patient office or other outpatient visit, 30-39 minutes

Infusion into a vein for hydration, 31-60 minutes

Injection of drug or substance into vein

Carcinoembryonic antigen (cea) protein level

Established patient office or other outpatient visit, 20-29 minutes

Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle

Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less

Administration of chemotherapy into vein, each additional hour

Psa (prostate specific antigen) measurement, total

Injection, pembrolizumab, 1 mg

Telephone medical discussion with physician, 5-10 minutes

Irrigation of implanted venous access drug delivery device

Blood test, thyroid stimulating hormone (tsh)

Injection of drug or substance under skin or into muscle

Vitamin d-3 level

Cyanocobalamin (vitamin b-12) level

Application of on-body injector for under skin injection

Folic acid level, serum

Injection, bortezomib, 0.1 mg

Ferritin (blood protein) level

Injection of additional new drug or substance into vein

Infusion into a vein for therapy, prevention, or diagnosis, each additional hour

Gammaglobulin (immune system protein) measurement

Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion

Immunologic analysis technique on serum (immunofixation)

Blood test, comprehensive group of blood chemicals

Infusion into a vein for hydration, each additional hour

Measurement of immunoglobulin light chains

Iron binding capacity

Cortisol (hormone) measurement, total

Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count

Injection, denosumab, 1 mg

Magnesium level

Iron level